Amid preclinical-clinical transition, cancer vaccine firm CEO talks business, licensing & science
With preclinical studies and a new licensing deal under its belt, immunotherapy drug developer PDS Biotechnology is getting its manufacturing plans in place and preparing to file an IND in next month or two so it can begin clinical trials of a therapeutic vaccine for HPV-related cancers. In an interview with MedCity News, President and […]
